Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arrowhead PharmaceuticalsNektar TherapeuticsGlobal Blood TherapeuticsZai LabEmergent Biosolutions
SymbolNASDAQ:ARWRNASDAQ:NKTRNASDAQ:GBTNASDAQ:ZLABNYSE:EBS
Price Information
Current Price$32.01$22.63$68.81$76.00$86.35
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.81.61.11.4
Analysis Score4.44.34.41.52.4
Community Score2.53.03.02.32.7
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.01.01.0
Earnings & Valuation Score0.00.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$62.00$32.00$105.13$57.31$83.86
% Upside from Price Target93.69% upside41.41% upside52.79% upside-24.59% downside-2.89% downside
Trade Information
Market Cap$3.34 billion$3.88 billion$4.19 billion$4.42 billion$4.68 billion
Beta1.761.981.91.111.27
Average Volume1,161,6741,171,081790,657541,487507,433
Sales & Book Value
Annual Revenue$168.80 million$114.62 million$2.11 million$12.98 million$1.11 billion
Price / Sales19.3035.141,987.34340.184.09
Cashflow$0.76 per shareN/AN/AN/A$4.98 per share
Price / Cash42.28N/AN/AN/A17.33
Book Value$2.57 per share$7.99 per share$9.61 per share$5.07 per share$21.08 per share
Price / Book12.462.837.1614.994.10
Profitability
Net Income$67.97 million$-440,670,000.00$-266,770,000.00$-195,070,000.00$54.50 million
EPS$0.69($2.52)($4.71)($3.03)$2.91
Trailing P/E Ratio355.71N/AN/AN/A66.42
Forward P/E RatioN/AN/AN/AN/A25.78
P/E GrowthN/AN/AN/AN/AN/A
Net Margins6.86%-335.50%N/AN/A6.15%
Return on Equity (ROE)2.61%-28.83%-48.56%N/A14.58%
Return on Assets (ROA)2.08%-20.58%-39.45%N/A6.59%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.11%0.30%N/A0.71%
Current Ratio5.90%3.79%9.07%6.27%3.03%
Quick Ratio5.90%3.75%8.83%6.14%1.83%
Ownership Information
Institutional Ownership Percentage64.26%98.20%N/A78.29%85.61%
Insider Ownership Percentage4.00%2.99%4.30%N/A14.10%
Miscellaneous
Employees1166181713091,834
Shares Outstanding101.77 million177.99 million60.94 million58.10 million52.43 million
Next Earnings Date8/3/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)N/A8/6/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.